Heterocyclic compounds and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9775844
SERIAL NO

14661656

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INFINITY PHARMACEUTICALS, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Castro, Alfredo C Woburn, US 131 2651
Evans, Catherine A Somerville, US 51 1472
Janardanannair, Somarajannair Woburn, US 30 1015
Kutok, Jeffery L Natick, US 30 347
Lescarbeau, Andre Somerville, US 45 1373
Liu, Tao Wellesley, US 613 3850
Palombella, Vito J Needham, US 15 323
Tremblay, Martin R Melrose, US 46 1499
Winkler, David G Arlington, US 40 1573

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 3, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00